K03: Molecular determinants of therapy response in metastatic clear cell renal cell cancer (MORE-2)

HIPO Investigator:

Prof. Dr. Holger Sültmann


Supported by: HIPO

Entity: Renal Cell Cancer (RCC)

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.